TravelCenters of America Inc. Announces First Quarter 2023 Financial Results

Stock Information for TCR2 Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About TCR2 Therapeutics Inc.

Media Advisory: TransAlta and TransAlta Renewables Second Quarter 2023 Results and Conference Call
TravelCenters of America Inc. Announces Intention to Delist 8.25% Senior Notes Due 2028, 8.00% Senior Notes Due 2029, and 8.00% Senior Notes Due 2030 (Nasdaq: TANNI; TANNL; TANNZ) from the Nasdaq
bp expands mobility and convenience network completing the purchase of leading travel center operator, TravelCenters of America
TravelCenters of America Stockholders Approve Pending BP Transaction
Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend TA Shareholders Vote "FOR" Pending BP Transaction
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHBI, CBIO, TA, ASRT
SHAREHOLDER ALERT: Weiss Law Reminds MLVF, SHBI, CBIO, and TA Shareholders About Its Ongoing Investigations
Moore Kuehn Encourages SGEN, TA, MNTV, and UNVR Investors to Contact Law Firm

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.